Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1985-06-20
1988-05-10
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
560170, C07C10118, A61K 3122
Patent
active
047436212
ABSTRACT:
Carnitine acetyl carnitate dichloride, a precursor of carnitine and acetyl carnitine, is prepared by condensing noncarnitine tert-butyl ester with the acid chloride of acetyl carnitine chloride and methylating the product of the condensation with methyl iodide, thereby obtaining acetyl carnitate of carnitine chloride iodide. This product is hydrolized with trifluoroacetic acid, thereby eliminating the tert-butyl ester. The so-obtained acetyl carnitate of carnitine chloride iodide is converted into the desired compound by eluting a solution of the chloride iodide on a strongly basic ion-exchange resin activated in Cl.sup.- form.
REFERENCES:
patent: 4439438 (1984-03-01), Cavazza
patent: 4443475 (1984-04-01), Cavazza
patent: 4551477 (1985-11-01), Cavazza
Wagner, "Synthetic Organic Chemistry," pp. 479-482, (1953).
Comber, Org. Prep. Proced. Int., 17, pp. 175-181, (1985).
McOmie, "Protective Groups in Organic Chemistry," pp. 183-185 & 192-196, (1973).
Collins Bruce M.
Shippen Michael L.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Ester of acetyl carnitine, processes for its preparation and pha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ester of acetyl carnitine, processes for its preparation and pha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ester of acetyl carnitine, processes for its preparation and pha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321341